Moderna cuts sales forecast on weaker vaccine demand
Moderna ( MRNA) cut its 2025 forecast by $1 billion Monday, citing weak demand for its newest vaccine as well as slow sales ...
Drugmaker GSK Buys US Firm Focused On Gastro Cancer
British pharmaceutical company GSK on Monday said it had agreed to buy a US company that specialises in the treatment of rare gastrointestinal cancer GIST.